McKesson Corporation
MCKMcKesson Corporation (MCK) is a healthcare services and information technology company that distributes pharmaceuticals, medical supplies, and healthcare technology solutions. Founded in 1833, it has grown to become one of the largest healthcare distribution companies in North America, providing essential services to pharmacies, hospitals, and healthcare providers worldwide.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 2, 2026 | $0.82 | 2025-12-01 | 2025-12-01 |
| October 1, 2025 | $0.82 | 2025-09-02 | 2025-09-02 |
| July 1, 2025 | $0.71 | 2025-06-02 | 2025-06-02 |
| April 1, 2025 | $0.71 | 2025-03-03 | 2025-03-03 |
| January 2, 2025 | $0.71 | 2024-12-02 | 2024-12-02 |
Dividends Summary
- Consistent Payer: McKesson Corporation has rewarded shareholders with 88 dividend payments over the past 22 years.
- Total Returned Value: Investors who held MCK shares during this period received a total of $25.90 per share in dividend income.
- Latest Payout: The most recent dividend of $0.82/share was paid 21 days ago, on January 2, 2026.
- Yield & Schedule: MCK currently pays dividends quarterly with an annual yield of 0.37%.
- Dividend Growth: Since 2004, the dividend payout has grown by 1266.7%, from $0.06 to $0.82.
- Dividend Reliability: MCK has maintained or increased its dividend for 88 consecutive payments.
Company News
AOP Health US announced expanded distribution of Rapiblyk™ (landiolol), an FDA-approved ultra-short-acting beta-blocker for treating rapid heart rates in critical care settings. The drug is now available through four major pharmaceutical wholesalers: Cardinal, Cencora Specialty Distribution, McKesson Corporation, and Morris & Dickson, enhancing...
Zuckerman Investment Group increased its Henry Schein stake by 72,040 shares in Q3, bringing its position to 281,339 shares valued at $18.67 million. The purchase reflects confidence in Henry Schein's improving fundamentals, including 5% revenue growth to $3.3 billion, 13% non-GAAP EPS growth to $1.38, and a new $200 million efficiency plan. The ...
The global automated pharmacy compounding systems market is projected to grow from USD 2.95 billion in 2025 to USD 5.27 billion by 2035, driven by the need to reduce medication errors, demand for personalized medicine, and stringent regulatory standards.
Iterum Therapeutics reports expanding market access for ORLYNVAH™, securing nearly 25% insurance coverage in the U.S. and signing a Medicare Part D rebate agreement with a top Pharmacy Benefit Manager, with potential coverage starting in Q1 2026.
The global healthcare supply chain management market is projected to grow from $3.60 billion in 2025 to $9.20 billion by 2034, with a CAGR of 11.05%. North America leads the market, driven by technological advancements, AI integration, and demand for efficient healthcare logistics.
